DE3750474T2 - Bestimmung von Bakteriuria. - Google Patents

Bestimmung von Bakteriuria.

Info

Publication number
DE3750474T2
DE3750474T2 DE3750474T DE3750474T DE3750474T2 DE 3750474 T2 DE3750474 T2 DE 3750474T2 DE 3750474 T DE3750474 T DE 3750474T DE 3750474 T DE3750474 T DE 3750474T DE 3750474 T2 DE3750474 T2 DE 3750474T2
Authority
DE
Germany
Prior art keywords
bacteria
urine
detected
examination
bacteriuria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3750474T
Other languages
English (en)
Other versions
DE3750474D1 (de
Inventor
Edwards S Hyman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE3750474D1 publication Critical patent/DE3750474D1/de
Application granted granted Critical
Publication of DE3750474T2 publication Critical patent/DE3750474T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3750474T 1987-06-12 1987-06-12 Bestimmung von Bakteriuria. Expired - Fee Related DE3750474T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87305254A EP0294529B1 (de) 1987-06-12 1987-06-12 Bestimmung von Bakteriuria

Publications (2)

Publication Number Publication Date
DE3750474D1 DE3750474D1 (de) 1994-10-06
DE3750474T2 true DE3750474T2 (de) 1994-12-22

Family

ID=8197944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750474T Expired - Fee Related DE3750474T2 (de) 1987-06-12 1987-06-12 Bestimmung von Bakteriuria.

Country Status (3)

Country Link
EP (1) EP0294529B1 (de)
AT (1) ATE110787T1 (de)
DE (1) DE3750474T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992365A (en) * 1984-04-23 1991-02-12 Hyman Edward S Method of detecting bacteria in urine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54119992A (en) * 1978-03-10 1979-09-18 Lion Dentifrice Co Ltd Reagent for measuring quantity of bacteria relating to disease around tooth
CA1112987A (en) * 1978-09-25 1981-11-24 Joseph L. Melnick Staining and analysis of bacteria
DE3048294A1 (de) * 1980-12-20 1982-07-08 Carlos Prof. Dr. 7808 Waldkirch Thomas "verfahren und vorrichtung zur entwaesserung und/oder entfettung von gewebeproben"
HU184903B (en) * 1981-11-20 1984-11-28 Reanal Finomvegyszergyar Paint composition for biopsy examinations

Also Published As

Publication number Publication date
ATE110787T1 (de) 1994-09-15
EP0294529A1 (de) 1988-12-14
EP0294529B1 (de) 1994-08-31
DE3750474D1 (de) 1994-10-06

Similar Documents

Publication Publication Date Title
Nottebrock et al. Thymidine concentrations in serum and urine of different animal species and man
Diaz et al. Bullous pemphigoid antigen: isolation from normal human skin
AU3575089A (en) Method of detecting bacteria in urine
Guttman et al. Significance of cephalin-cholesterol flocculation test in malarial fever
ATE44621T1 (de) Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung.
DE3750474D1 (de) Bestimmung von Bakteriuria.
ATE105086T1 (de) Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b.
Kirkpatrick Jr et al. Whipple's disease: a case report with immunological studies
EP0070656B1 (de) Immobilisierte Superoxyd-dismutase, ihre Herstellung und pharmazeutische Zusammensetzung
Angel et al. A controlled comparison of cycloserine plus ethionamide with cycloserine plus thiacetazone in patients with active pulmonary tuberculosis despite prolonged previous chemotherapy
FR2608767B1 (fr) Procede pour la detection et le dosage des anticorps anti-(sporozoaires de p. falciparum) dans le sang humain et trousses de diagnostic pour mettre en oeuvre ce procede
Fiszer-Szafarz et al. Hyaluronic acid content of the interstitial fluid of Walker carcinoma 256
Witebsky et al. Distribution of blood group properties and blood group property destroying factors in the intestinal tract of man
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
AU7059187A (en) Method for the detection of pregnancy disorders
Burioni et al. Lyme disease in Italy: isolation of Borrelia burgdorferi from a patient
Yaegaki et al. Influence of aging on DNase activity in human parotid saliva
ØDUM et al. Electrophoretic investigations of acid-stable proteinase-inhibitory activity in human serum
Horowitz et al. Blood group substances in canine gastric mucus and acid secretion.
Walter et al. Effect of oxidized glutathione on some enzymes of erythrocytes and its relation to erythrocytic enzyme activity and electrophoretic mobility
Hall et al. Improved method for the extraction of vitamin B12 from serum
Dornbusch et al. Antibacterial activity of cefuroxime in human bone
Klemperer et al. Necrotizing factor in human sera
Budtz‐Jörgensen et al. Leukocyte migration inhibition by dental plaque antigens as indicated by the capillary tube and the agarose plate technique
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee